These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19476760)

  • 1. Hearing loss owing to intralabyrinthine schwannoma responsive to intratympanic steroid treatment.
    Iseri M; Ulubil SA; Topdag M; Oran A
    J Otolaryngol Head Neck Surg; 2009 Jun; 38(3):E95-7. PubMed ID: 19476760
    [No Abstract]   [Full Text] [Related]  

  • 2. [Localizing the cause for unilateral sensorineural hearing loss].
    Rihkanen H; Ramsay H; Marttila T; Markkola A; Blomstedt G; Ylikoski J
    Duodecim; 2002; 118(17):1787-92. PubMed ID: 12370986
    [No Abstract]   [Full Text] [Related]  

  • 3. Intratympanic steroid prevents long-term spiral ganglion neuron loss in experimental meningitis.
    Worsøe L; Brandt CT; Lund SP; Ostergaard C; Thomsen J; Cayé-Thomasen P
    Otol Neurotol; 2010 Apr; 31(3):394-403. PubMed ID: 20147868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing evaluation of intratympanic methylprednisolone perfusion for refractory sudden sensorineural hearing loss.
    Lee DH
    Otolaryngol Head Neck Surg; 2010 Jun; 142(6):922-3; author reply 923. PubMed ID: 20493378
    [No Abstract]   [Full Text] [Related]  

  • 6. Progressive hearing loss in intracochlear schwannoma.
    Nishimura T; Hosoi H
    Eur Arch Otorhinolaryngol; 2008 Apr; 265(4):489-92. PubMed ID: 17932683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravestibular space occupying lesions of lipoma and schwannoma.
    Choi JS; Kim YH; Han CD; Kim KS
    Auris Nasus Larynx; 2012 Aug; 39(4):431-3. PubMed ID: 22119483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.
    Wu HP; Chou YF; Yu SH; Wang CP; Hsu CJ; Chen PR
    Otol Neurotol; 2011 Jul; 32(5):774-9. PubMed ID: 21646929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily short-term intratympanic dexamethasone treatment alone as an initial or salvage treatment for idiopathic sudden sensorineural hearing loss.
    Kakehata S; Sasaki A; Futai K; Kitani R; Shinkawa H
    Audiol Neurootol; 2011; 16(3):191-7. PubMed ID: 20962524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of intralabyrinthine schwannomas.
    Green JD; McKenzie JD
    Laryngoscope; 1999 Oct; 109(10):1626-31. PubMed ID: 10522933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss.
    Gouveris H; Schuler-Schmidt W; Mewes T; Mann W
    Otol Neurotol; 2011 Jul; 32(5):756-60. PubMed ID: 21646933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intracochlear schwannomas: differential diagnosis in menière-like vestibulocochlear symptoms].
    Just T; Hingst V; Pau HW
    Laryngorhinootologie; 2010 Jun; 89(6):368-70. PubMed ID: 20108197
    [No Abstract]   [Full Text] [Related]  

  • 13. Intralabyrinthine Vestibular Schwannoma Responsive to Intratympanic Gentamicin Treatment.
    Covelli E; Volpini L; Filippi C; Tarantini S; Marrone V; Monini S; Barbara M
    J Int Adv Otol; 2017 Aug; 13(2):285-288. PubMed ID: 28816698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of vestibular evoked myogenic potentials with modified translabyrinthine approach.
    Magliulo G; Parrotto D; Cuiuli G; Alla FR; Gagliardi M
    Arch Otolaryngol Head Neck Surg; 2007 Jul; 133(7):720-3. PubMed ID: 17638788
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss.
    Park MK; Lee CK; Park KH; Lee JD; Lee CG; Lee BD
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1016-21. PubMed ID: 21817157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglycemia after intratympanic dexamethasone treatment in a diabetic patient.
    Gallegos-Constantino V; Cervera-Paz FJ; Salvador J; Ba FK; Perez-Fernandez N
    Rev Laryngol Otol Rhinol (Bord); 2011; 132(3):153-5. PubMed ID: 22533068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of cerebellopontine space imaging by magnetic resonance during one year.
    Decat M; Cosnard G; Duprez T; Bauwens N; Gersdorff M
    Acta Otorhinolaryngol Belg; 2000; 54(4):437-41. PubMed ID: 11205445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential diagnosis of unilateral hearing loss].
    Reiss M; Reiss G
    Praxis (Bern 1994); 2000 Feb; 89(6):241-7. PubMed ID: 10783670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intralabyrinthine schwannoma of the vestibulocochlear nerve].
    Brozek-Madry E; Niemczyk K; Morawski K
    Otolaryngol Pol; 2009; 63(5):437-41. PubMed ID: 20169910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratympanic methylprednisolone improves hearing function in refractory sudden sensorineural hearing loss: a control study.
    Li P; Zeng XL; Ye J; Yang QT; Zhang GH; Li Y
    Audiol Neurootol; 2011; 16(3):198-202. PubMed ID: 20948195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.